Vorapaxar-d5 | CAS 705260-08-8

Vorapaxar-d5 is a stable isotope-labeled analogue of Vorapaxar, in which five hydrogen atoms are replaced with deuterium (²H). This isotopically labeled reference standard is widely used as an internal standard (IS) in LC-MS/MS-based quantitative bioanalysis, pharmacokinetic (PK) studies, bioequivalence (BE) testing, therapeutic drug monitoring (TDM), metabolism research, and analytical method validation. The deuterium labeling enables accurate correction for extraction variability, ion suppression, matrix effects, and instrument response fluctuations while maintaining nearly identical chromatographic behavior to the unlabeled analyte. Stable isotope-labeled Vorapaxar standards are routinely used during regulated bioanalytical studies to achieve high precision and reproducibility in accordance with FDA and ICH bioanalytical method validation expectations.

Vorapaxar itself is a selective protease-activated receptor-1 (PAR-1) antagonist that inhibits thrombin-induced platelet activation. It is approved for reducing thrombotic cardiovascular events in selected patients with a history of myocardial infarction or peripheral arterial disease. Because Vorapaxar exhibits a long elimination half-life, extensive tissue distribution, and low plasma concentrations during pharmacokinetic evaluation, highly sensitive LC-MS/MS methods incorporating Vorapaxar-d5 are essential for reliable quantification across a broad concentration range.

Applications of Vorapaxar-d5:

Vorapaxar-d5 is extensively utilized by pharmaceutical companies, CROs, academic laboratories, and regulatory testing facilities during drug discovery and clinical development. Common applications include:

• LC-MS/MS quantitative bioanalysis
• Pharmacokinetic (PK) studies
• Bioequivalence (BE) studies
• Clinical and preclinical bioanalysis
• Plasma and serum drug quantification
• Method development and validation
• Therapeutic drug monitoring research
• Metabolite profiling
• Drug-drug interaction studies
• Stability and degradation investigations
• Quality control laboratories
• Analytical reference standard qualification

Its isotopic labeling ensures that the internal standard co-elutes with Vorapaxar while remaining distinguishable by mass spectrometry, allowing compensation for analytical variability throughout sample preparation and instrumental analysis.

Benefits of Using a Stable Isotope-Labeled Internal Standard

Quantitative LC-MS/MS assays require internal standards that mimic the behavior of the analyte throughout extraction, chromatography, and ionization. Vorapaxar-d5 fulfills these requirements because its chemical structure is almost identical to native Vorapaxar while providing a measurable mass difference.

Major advantages include:

• Excellent correction for matrix effects
• Improved assay accuracy and precision
• Enhanced reproducibility between analytical batches
• Compensation for extraction losses
• Reduced analytical variability
• Improved recovery during sample preparation
• Reliable quantification at trace concentration levels
• Increased confidence during regulatory submissions
• Compatibility with validated LC-MS/MS workflows

These advantages are particularly valuable when analyzing complex biological matrices such as human plasma, serum, or whole blood where endogenous components can influence ionization efficiency.

Role in Bioanalytical Method Development

During bioanalytical method development, Vorapaxar-d5 supports optimization of sample preparation procedures including protein precipitation, liquid-liquid extraction (LLE), and solid-phase extraction (SPE). It is incorporated before extraction to monitor recovery efficiency and compensate for losses occurring during sample processing.

Analytical scientists also employ Vorapaxar-d5 while optimizing:

• Chromatographic separation
• Mobile phase composition
• Gradient development
• MS/MS transitions
• Collision energies
• Source parameters
• Sensitivity optimization
• Calibration curve performance
• Lower limit of quantification (LLOQ)
• Carryover assessment

Because the internal standard experiences nearly identical analytical conditions as the analyte, it significantly improves quantitative robustness during routine laboratory operations.

Pharmacokinetic and Clinical Research Applications

Reliable quantification of Vorapaxar concentrations is essential for understanding drug exposure, absorption, metabolism, and elimination characteristics. Vorapaxar-d5 is routinely incorporated into validated bioanalytical methods supporting:

• Phase I clinical trials
• Phase II clinical development
• Phase III studies
• Bioequivalence investigations
• Population pharmacokinetics
• Drug interaction studies
• Toxicokinetic evaluations
• Dose proportionality studies
• Regulatory submission packages

Stable isotope-labeled internal standards improve confidence in generated concentration data, supporting accurate pharmacokinetic modeling and regulatory decision-making.

Analytical Techniques Compatible with Vorapaxar-d5

Vorapaxar-d5 is compatible with numerous modern analytical platforms used in pharmaceutical laboratories, including:

• LC-MS/MS
• UHPLC-MS/MS
• HPLC-MS/MS
• Triple quadrupole mass spectrometry
• High-resolution mass spectrometry (HRMS)
• Orbitrap LC-MS
• QTOF LC-MS
• Method transfer studies
• GMP quality control testing
• Bioanalytical assay validation

These techniques provide high sensitivity, selectivity, and reproducibility required for regulated pharmaceutical research.

Quality Considerations

For regulated pharmaceutical applications, isotope-labeled reference standards should demonstrate:

• High chemical purity
• High isotopic enrichment
• Structural identity confirmation
• Batch-to-batch consistency
• Comprehensive Certificate of Analysis (CoA)
• Proper storage stability
• Traceable analytical characterization

High-quality internal standards contribute directly to successful method validation and consistent analytical performance throughout product development.

Why Choose ResolveMass Laboratories Inc.?

ResolveMass Laboratories Inc. provides advanced mass spectrometry solutions supporting pharmaceutical, biotechnology, and generic drug development programs. Our experienced scientists develop and validate highly sensitive LC-MS/MS methods utilizing stable isotope-labeled internal standards such as Vorapaxar-d5 for quantitative bioanalysis.

Our capabilities include:

• Stable isotope-labeled reference standard support
• LC-MS/MS method development
• Bioanalytical method validation
• Pharmacokinetic sample analysis
• Biomarker quantification
• Clinical and preclinical bioanalysis
• Impurity profiling
• Metabolite identification
• Regulatory-compliant analytical studies
• Customized analytical solutions for drug development

Using state-of-the-art instrumentation and scientifically rigorous workflows, ResolveMass delivers accurate, reproducible, and regulatory-ready analytical data that accelerates pharmaceutical research and development.

Whether supporting early discovery, clinical trials, or commercial product lifecycle management, Vorapaxar-d5 remains an indispensable internal standard for precise LC-MS/MS quantification, enabling reliable pharmacokinetic evaluation and high-quality bioanalytical data generation for modern cardiovascular drug research.

Learn more about Deuterated Chemicals through,

• Deuterated Polymers: A Cornerstone Guide to Synthesis, Applications, and Future Trends
• Availability of All the Deuterated Chemicals at ResolveMass Laboratories Inc. 
• ResolveMass Laboratories: Leading Deuterated Chemical Synthesis Company in the United States.
• Deuterated Internal Standards for LC-MS: Selection & Custom Synthesis 
• How to Choose the Right Deuterated Labelled Chemical Synthesis Company in Canada 
• How to Choose the Right Deuterium Labelled Compounds Supplier for Your Lab 
• Deuterium-Labelled Compounds — Synthesis, Applications & Ordering 
• Custom Synthesis of Deuterated Chemicals